February 15, 2018
Rose
Digital diabetes care company Glooko announced today that its Mobile Insulin Dosing System (MIDS) — an app-driven tool that recommends insulin dose adjustments using data collected directly from a patient’s blood glucose meter — has been cleared by the FDA.
from MobiHealthNews http://ift.tt/2HgUzri
February 15, 2018
Rose
MobiHealthNews
No comments
Related Posts:
Optum, UnitedHealthcare, Humana, others launch blockchain pilot- Roundup: FDA digital health clearances and news in Q1 2018
- FallCall Solutions secures seed funding for Apple Watch-based PERS, fall detection
- WebMD's new symptom checker ditches avatar, adds professional CDS tool
- Roundup: Digital health payer news of Q1 2018
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment